MediumCardiologyHeart failure with reduced ejection fractionca-mccqe1ca-rcpsc-im
A 69-year-old man with ischaemic cardiomyopathy (LVEF 30%) is clinically euvolemic. He is on ramipril 10 mg daily and bisoprolol 5 mg daily but no other heart failure medications. According to Canadian heart failure guidelines, what is the next most appropriate disease-modifying therapy to add if there are no contraindications?